Oxygenta Pharmaceutical informs about outcome of board meeting

14 Aug 2023 Evaluate
Oxygenta Pharmaceutical has informed that the Board of Directors of the Company at its just concluded meeting has, transacted the following items of business: Approved the Un-Audited financial results for the First Quarter ended on 30th June, 2023; Took note of the Limited Review Report on Un-Audited financial results for the first quarter ended on 30th June, 2023 issued by the Statutory Auditors of the Company; Accepted the resignation of statutory auditors of the company Gowri Shankar and Associates. Disclosure as per regulation 30 of SEBI (LODR) regulations, 2015 has already been given; Disclosure under Regulation 32(1) of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 copy enclosed as Annexure-I. The meeting commenced at 04.00 PM and concluded at 04.30 PM.

The above information is a part of company’s filings submitted to BSE.

Oxygenta Pharma Share Price

90.14 -1.83 (-1.99%)
20-Dec-2024 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1808.50
Dr. Reddys Lab 1342.45
Cipla 1472.45
Lupin 2147.55
Zydus Lifesciences 973.90
View more..
© 2024 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.